Global Diagnostic Radiopharmaceuticals Market Size, Share, Trends and Forecast 2022-2030

Radiopharmaceuticals refer to a class of special medicines containing radionuclides for medical diagnosis and treatment. Compounds or biological preparations containing radionuclide labels used for medical diagnosis or treatment in the body. Diagnostic radiopharmaceuticals are radioisotopes that bind to biomolecules that can locate specific organs, tissues or cells in the body. These radiopharmaceuticals can be used to diagnose diseases.
Industry Insights

Due to the COVID-19 pandemic, the global Diagnostic Radiopharmaceuticals market size is estimated to be worth US$ 4385.1 million in 2021 and is forecast to a readjusted size of US$ 7034 million by 2028 with a CAGR of 6.9% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Diagnostic Radiopharmaceuticals market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Diagnostic Radiopharmaceuticals landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

North America is the world's major consumer region, with sales accounting for 41.59% of the global total in 2019. Europe is also a major consumer region, accounting for 24.5% of the global market. China is also a very important consumer region due to the large number of cancers. At present, products represented by Cardinal Health, GE Healthcare, Curium Pharma, Jubilant Pharma, Bracco Imaging, etc. occupy a major position in the global market.

This report focuses on Diagnostic Radiopharmaceuticals volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Diagnostic Radiopharmaceuticals market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Post-covid-19 Outlook

The readers in the section will understand how the Diagnostic Radiopharmaceuticals market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Segmental Outlook

Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).

Segment by Type

Technetium 99

Fluorine 18

Other

Segment by Application

Oncology

Cardiology

Other

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Scenario

In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Cardinal Health

GE Healthcare

Curium Pharma

Jubilant Pharma

Bracco Imaging

Advanced Accelerator Applications

SIEMENS

China Isotope & Radiation

Dongcheng Pharmaceutical Group

Lantheus

Eli Lilly

1 Diagnostic Radiopharmaceuticals Market Overview
1.1 Product Overview and Scope of Diagnostic Radiopharmaceuticals

1.2 Diagnostic Radiopharmaceuticals Segment by Type

1.2.1 Global Diagnostic Radiopharmaceuticals Sales Growth Rate Comparison by Type (2022-2028)

1.2.2 Technetium 99

1.2.3 Fluorine 18

1.2.4 Other

1.3 Diagnostic Radiopharmaceuticals Segment by Application

1.3.1 Global Diagnostic Radiopharmaceuticals Sales Comparison by Application: (2022-2028)

1.3.2 Oncology

1.3.3 Cardiology

1.3.4 Other

1.4 Global Diagnostic Radiopharmaceuticals Market Size Estimates and Forecasts

1.4.1 Global Diagnostic Radiopharmaceuticals Revenue 2017-2028

1.4.2 Global Diagnostic Radiopharmaceuticals Sales 2017-2028

1.4.3 Diagnostic Radiopharmaceuticals Market Size by Region: 2017 Versus 2021 Versus 2028

2 Diagnostic Radiopharmaceuticals Market Competition by Manufacturers

2.1 Global Diagnostic Radiopharmaceuticals Sales Market Share by Manufacturers (2017-2022)

2.2 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Manufacturers (2017-2022)

2.3 Global Diagnostic Radiopharmaceuticals Average Price by Manufacturers (2017-2022)

2.4 Manufacturers Diagnostic Radiopharmaceuticals Manufacturing Sites, Area Served, Product Type

2.5 Diagnostic Radiopharmaceuticals Market Competitive Situation and Trends

2.5.1 Diagnostic Radiopharmaceuticals Market Concentration Rate

2.5.2 The Global Top 5 and Top 10 Largest Diagnostic Radiopharmaceuticals Players Market Share by Revenue

2.5.3 Global Diagnostic Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Diagnostic Radiopharmaceuticals Retrospective Market Scenario by Region

3.1 Global Diagnostic Radiopharmaceuticals Retrospective Market Scenario in Sales by Region: 2017-2022

3.2 Global Diagnostic Radiopharmaceuticals Retrospective Market Scenario in Revenue by Region: 2017-2022

3.3 North America Diagnostic Radiopharmaceuticals Market Facts & Figures by Country

3.3.1 North America Diagnostic Radiopharmaceuticals Sales by Country

3.3.2 North America Diagnostic Radiopharmaceuticals Revenue by Country

3.3.3 U.S.

3.3.4 Canada

3.4 Europe Diagnostic Radiopharmaceuticals Market Facts & Figures by Country

3.4.1 Europe Diagnostic Radiopharmaceuticals Sales by Country

3.4.2 Europe Diagnostic Radiopharmaceuticals Revenue by Country

3.4.3 Germany

3.4.4 France

3.4.5 U.K.

3.4.6 Italy

3.4.7 Russia

3.5 Asia Pacific Diagnostic Radiopharmaceuticals Market Facts & Figures by Region

3.5.1 Asia Pacific Diagnostic Radiopharmaceuticals Sales by Region

3.5.2 Asia Pacific Diagnostic Radiopharmaceuticals Revenue by Region

3.5.3 China

3.5.4 Japan

3.5.5 South Korea

3.5.6 India

3.5.7 Australia

3.5.8 Taiwan

3.5.9 Indonesia

3.5.10 Thailand

3.5.11 Malaysia

3.5.12 Philippines

3.5.13 Vietnam

3.6 Latin America Diagnostic Radiopharmaceuticals Market Facts & Figures by Country

3.6.1 Latin America Diagnostic Radiopharmaceuticals Sales by Country

3.6.2 Latin America Diagnostic Radiopharmaceuticals Revenue by Country

3.6.3 Mexico

3.6.4 Brazil

3.6.5 Argentina

3.7 Middle East and Africa Diagnostic Radiopharmaceuticals Market Facts & Figures by Country

3.7.1 Middle East and Africa Diagnostic Radiopharmaceuticals Sales by Country

3.7.2 Middle East and Africa Diagnostic Radiopharmaceuticals Revenue by Country

3.7.3 Turkey

3.7.4 Saudi Arabia

3.7.5 UAE

4 Global Diagnostic Radiopharmaceuticals Historic Market Analysis by Type

4.1 Global Diagnostic Radiopharmaceuticals Sales Market Share by Type (2017-2022)

4.2 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Type (2017-2022)

4.3 Global Diagnostic Radiopharmaceuticals Price by Type (2017-2022)

5 Global Diagnostic Radiopharmaceuticals Historic Market Analysis by Application

5.1 Global Diagnostic Radiopharmaceuticals Sales Market Share by Application (2017-2022)

5.2 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Application (2017-2022)

5.3 Global Diagnostic Radiopharmaceuticals Price by Application (2017-2022)

6 Key Companies Profiled

6.1 Cardinal Health

6.1.1 Cardinal Health Corporation Information

6.1.2 Cardinal Health Description and Business Overview

6.1.3 Cardinal Health Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2017-2022)

6.1.4 Cardinal Health Diagnostic Radiopharmaceuticals Product Portfolio

6.1.5 Cardinal Health Recent Developments/Updates

6.2 GE Healthcare

6.2.1 GE Healthcare Corporation Information

6.2.2 GE Healthcare Description and Business Overview

6.2.3 GE Healthcare Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2017-2022)

6.2.4 GE Healthcare Diagnostic Radiopharmaceuticals Product Portfolio

6.2.5 GE Healthcare Recent Developments/Updates

6.3 Curium Pharma

6.3.1 Curium Pharma Corporation Information

6.3.2 Curium Pharma Description and Business Overview

6.3.3 Curium Pharma Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2017-2022)

6.3.4 Curium Pharma Diagnostic Radiopharmaceuticals Product Portfolio

6.3.5 Curium Pharma Recent Developments/Updates

6.4 Jubilant Pharma

6.4.1 Jubilant Pharma Corporation Information

6.4.2 Jubilant Pharma Description and Business Overview

6.4.3 Jubilant Pharma Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2017-2022)

6.4.4 Jubilant Pharma Diagnostic Radiopharmaceuticals Product Portfolio

6.4.5 Jubilant Pharma Recent Developments/Updates

6.5 Bracco Imaging

6.5.1 Bracco Imaging Corporation Information

6.5.2 Bracco Imaging Description and Business Overview

6.5.3 Bracco Imaging Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2017-2022)

6.5.4 Bracco Imaging Diagnostic Radiopharmaceuticals Product Portfolio

6.5.5 Bracco Imaging Recent Developments/Updates

6.6 Advanced Accelerator Applications

6.6.1 Advanced Accelerator Applications Corporation Information

6.6.2 Advanced Accelerator Applications Description and Business Overview

6.6.3 Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2017-2022)

6.6.4 Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Product Portfolio

6.6.5 Advanced Accelerator Applications Recent Developments/Updates

6.7 SIEMENS

6.6.1 SIEMENS Corporation Information

6.6.2 SIEMENS Description and Business Overview

6.6.3 SIEMENS Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2017-2022)

6.4.4 SIEMENS Diagnostic Radiopharmaceuticals Product Portfolio

6.7.5 SIEMENS Recent Developments/Updates

6.8 China Isotope & Radiation

6.8.1 China Isotope & Radiation Corporation Information

6.8.2 China Isotope & Radiation Description and Business Overview

6.8.3 China Isotope & Radiation Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2017-2022)

6.8.4 China Isotope & Radiation Diagnostic Radiopharmaceuticals Product Portfolio

6.8.5 China Isotope & Radiation Recent Developments/Updates

6.9 Dongcheng Pharmaceutical Group

6.9.1 Dongcheng Pharmaceutical Group Corporation Information

6.9.2 Dongcheng Pharmaceutical Group Description and Business Overview

6.9.3 Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2017-2022)

6.9.4 Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Product Portfolio

6.9.5 Dongcheng Pharmaceutical Group Recent Developments/Updates

6.10 Lantheus

6.10.1 Lantheus Corporation Information

6.10.2 Lantheus Description and Business Overview

6.10.3 Lantheus Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2017-2022)

6.10.4 Lantheus Diagnostic Radiopharmaceuticals Product Portfolio

6.10.5 Lantheus Recent Developments/Updates

6.11 Eli Lilly

6.11.1 Eli Lilly Corporation Information

6.11.2 Eli Lilly Diagnostic Radiopharmaceuticals Description and Business Overview

6.11.3 Eli Lilly Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2017-2022)

6.11.4 Eli Lilly Diagnostic Radiopharmaceuticals Product Portfolio

6.11.5 Eli Lilly Recent Developments/Updates

7 Diagnostic Radiopharmaceuticals Manufacturing Cost Analysis

7.1 Diagnostic Radiopharmaceuticals Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Key Suppliers of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.3 Manufacturing Process Analysis of Diagnostic Radiopharmaceuticals

7.4 Diagnostic Radiopharmaceuticals Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

8.1 Marketing Channel

8.2 Diagnostic Radiopharmaceuticals Distributors List

8.3 Diagnostic Radiopharmaceuticals Customers

9 Diagnostic Radiopharmaceuticals Market Dynamics

9.1 Diagnostic Radiopharmaceuticals Industry Trends

9.2 Diagnostic Radiopharmaceuticals Market Drivers

9.3 Diagnostic Radiopharmaceuticals Market Challenges

9.4 Diagnostic Radiopharmaceuticals Market Restraints

10 Global Market Forecast

10.1 Diagnostic Radiopharmaceuticals Market Estimates and Projections by Type

10.1.1 Global Forecasted Sales of Diagnostic Radiopharmaceuticals by Type (2023-2028)

10.1.2 Global Forecasted Revenue of Diagnostic Radiopharmaceuticals by Type (2023-2028)

10.2 Diagnostic Radiopharmaceuticals Market Estimates and Projections by Application

10.2.1 Global Forecasted Sales of Diagnostic Radiopharmaceuticals by Application (2023-2028)

10.2.2 Global Forecasted Revenue of Diagnostic Radiopharmaceuticals by Application (2023-2028)

10.3 Diagnostic Radiopharmaceuticals Market Estimates and Projections by Region

10.3.1 Global Forecasted Sales of Diagnostic Radiopharmaceuticals by Region (2023-2028)

10.3.2 Global Forecasted Revenue of Diagnostic Radiopharmaceuticals by Region (2023-2028)

11 Research Finding and Conclusion

12 Methodology and Data Source

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Author List

12.4 Disclaimer